Global Gammaretroviral Vector Supply, Demand and Key Producers, 2023-2029

Description

The global Gammaretroviral Vector market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Gammaretroviruses are retroviral vectors in laboratory studies. These vectors are critical for gene therapy and gene transfer. They are so helpful because their genomes are simple and easy to use. Gammaretroviruses have a wide range of implications for animals. They have been linked to various diseases, including cancer, specifically leukemias and lymphomas, neurological diseases, and immunodeficiencies in multiple species. Gammaretroviruses, like other retroviruses, reverse transcribe a positive single strand RNA into double stranded DNA. The double-stranded DNA is highly stable and easily integrated into the host genome. Moloney murine leukaemia virus, xenotropic MuLB-related virus, feline leukaemia virus, and feline sarcoma virus are some examples of the virus.

This report studies the global Gammaretroviral Vector production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gammaretroviral Vector, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gammaretroviral Vector that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gammaretroviral Vector total production and demand, 2018-2029, (K Units)
Global Gammaretroviral Vector total production value, 2018-2029, (USD Million)
Global Gammaretroviral Vector production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gammaretroviral Vector consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gammaretroviral Vector domestic production, consumption, key domestic manufacturers and share
Global Gammaretroviral Vector production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gammaretroviral Vector production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gammaretroviral Vector production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Gammaretroviral Vector market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novasep, MerckKGaA, Charles River Laboratories, UniQure N.V., Waisman Biomanufacturing, Creative-Biogene, Aldevron, Addgene and Oxford Biomedica, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gammaretroviral Vector market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gammaretroviral Vector Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gammaretroviral Vector Market, Segmentation by Type
    Lentiviral Vectors
    Adenoviral Vectors
    Adeno-Associated Viral Vectors
    Other

Global Gammaretroviral Vector Market, Segmentation by Application
    Gene Therapy
    Vaccinology
    Other

Companies Profiled:
    Novasep
    MerckKGaA
    Charles River Laboratories
    UniQure N.V.
    Waisman Biomanufacturing
    Creative-Biogene
    Aldevron
    Addgene
    Oxford Biomedica
    Thermo Fisher Scientific Inc.
    Fujifilm Corporation
    Spark Therapeutics Inc
    ABL Inc
    Boehringer Ingelheim International GmbH
    Brammer Bio
    Creative Biogene
    General Electric
    Pfizer Inc

Key Questions Answered
1. How big is the global Gammaretroviral Vector market?
2. What is the demand of the global Gammaretroviral Vector market?
3. What is the year over year growth of the global Gammaretroviral Vector market?
4. What is the production and production value of the global Gammaretroviral Vector market?
5. Who are the key producers in the global Gammaretroviral Vector market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gammaretroviral Vector Introduction
    1.2 World Gammaretroviral Vector Supply & Forecast
        1.2.1 World Gammaretroviral Vector Production Value (2018 & 2022 & 2029)
        1.2.2 World Gammaretroviral Vector Production (2018-2029)
        1.2.3 World Gammaretroviral Vector Pricing Trends (2018-2029)
    1.3 World Gammaretroviral Vector Production by Region (Based on Production Site)
        1.3.1 World Gammaretroviral Vector Production Value by Region (2018-2029)
        1.3.2 World Gammaretroviral Vector Production by Region (2018-2029)
        1.3.3 World Gammaretroviral Vector Average Price by Region (2018-2029)
        1.3.4 North America Gammaretroviral Vector Production (2018-2029)
        1.3.5 Europe Gammaretroviral Vector Production (2018-2029)
        1.3.6 China Gammaretroviral Vector Production (2018-2029)
        1.3.7 Japan Gammaretroviral Vector Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gammaretroviral Vector Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gammaretroviral Vector Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gammaretroviral Vector Demand (2018-2029)
    2.2 World Gammaretroviral Vector Consumption by Region
        2.2.1 World Gammaretroviral Vector Consumption by Region (2018-2023)
        2.2.2 World Gammaretroviral Vector Consumption Forecast by Region (2024-2029)
    2.3 United States Gammaretroviral Vector Consumption (2018-2029)
    2.4 China Gammaretroviral Vector Consumption (2018-2029)
    2.5 Europe Gammaretroviral Vector Consumption (2018-2029)
    2.6 Japan Gammaretroviral Vector Consumption (2018-2029)
    2.7 South Korea Gammaretroviral Vector Consumption (2018-2029)
    2.8 ASEAN Gammaretroviral Vector Consumption (2018-2029)
    2.9 India Gammaretroviral Vector Consumption (2018-2029)

3 World Gammaretroviral Vector Manufacturers Competitive Analysis
    3.1 World Gammaretroviral Vector Production Value by Manufacturer (2018-2023)
    3.2 World Gammaretroviral Vector Production by Manufacturer (2018-2023)
    3.3 World Gammaretroviral Vector Average Price by Manufacturer (2018-2023)
    3.4 Gammaretroviral Vector Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Gammaretroviral Vector Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Gammaretroviral Vector in 2022
        3.5.3 Global Concentration Ratios (CR8) for Gammaretroviral Vector in 2022
    3.6 Gammaretroviral Vector Market: Overall Company Footprint Analysis
        3.6.1 Gammaretroviral Vector Market: Region Footprint
        3.6.2 Gammaretroviral Vector Market: Company Product Type Footprint
        3.6.3 Gammaretroviral Vector Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Gammaretroviral Vector Production Value Comparison
        4.1.1 United States VS China: Gammaretroviral Vector Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Gammaretroviral Vector Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Gammaretroviral Vector Production Comparison
        4.2.1 United States VS China: Gammaretroviral Vector Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gammaretroviral Vector Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Gammaretroviral Vector Consumption Comparison
        4.3.1 United States VS China: Gammaretroviral Vector Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Gammaretroviral Vector Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Gammaretroviral Vector Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Gammaretroviral Vector Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Gammaretroviral Vector Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Gammaretroviral Vector Production (2018-2023)
    4.5 China Based Gammaretroviral Vector Manufacturers and Market Share
        4.5.1 China Based Gammaretroviral Vector Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Gammaretroviral Vector Production Value (2018-2023)
        4.5.3 China Based Manufacturers Gammaretroviral Vector Production (2018-2023)
    4.6 Rest of World Based Gammaretroviral Vector Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Gammaretroviral Vector Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Gammaretroviral Vector Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Gammaretroviral Vector Production (2018-2023)

5 Market Analysis by Type
    5.1 World Gammaretroviral Vector Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Lentiviral Vectors
        5.2.2 Adenoviral Vectors
        5.2.3 Adeno-Associated Viral Vectors
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Gammaretroviral Vector Production by Type (2018-2029)
        5.3.2 World Gammaretroviral Vector Production Value by Type (2018-2029)
        5.3.3 World Gammaretroviral Vector Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gammaretroviral Vector Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Gene Therapy
        6.2.2 Vaccinology
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Gammaretroviral Vector Production by Application (2018-2029)
        6.3.2 World Gammaretroviral Vector Production Value by Application (2018-2029)
        6.3.3 World Gammaretroviral Vector Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Novasep
        7.1.1 Novasep Details
        7.1.2 Novasep Major Business
        7.1.3 Novasep Gammaretroviral Vector Product and Services
        7.1.4 Novasep Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Novasep Recent Developments/Updates
        7.1.6 Novasep Competitive Strengths & Weaknesses
    7.2 MerckKGaA
        7.2.1 MerckKGaA Details
        7.2.2 MerckKGaA Major Business
        7.2.3 MerckKGaA Gammaretroviral Vector Product and Services
        7.2.4 MerckKGaA Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 MerckKGaA Recent Developments/Updates
        7.2.6 MerckKGaA Competitive Strengths & Weaknesses
    7.3 Charles River Laboratories
        7.3.1 Charles River Laboratories Details
        7.3.2 Charles River Laboratories Major Business
        7.3.3 Charles River Laboratories Gammaretroviral Vector Product and Services
        7.3.4 Charles River Laboratories Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Charles River Laboratories Recent Developments/Updates
        7.3.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.4 UniQure N.V.
        7.4.1 UniQure N.V. Details
        7.4.2 UniQure N.V. Major Business
        7.4.3 UniQure N.V. Gammaretroviral Vector Product and Services
        7.4.4 UniQure N.V. Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 UniQure N.V. Recent Developments/Updates
        7.4.6 UniQure N.V. Competitive Strengths & Weaknesses
    7.5 Waisman Biomanufacturing
        7.5.1 Waisman Biomanufacturing Details
        7.5.2 Waisman Biomanufacturing Major Business
        7.5.3 Waisman Biomanufacturing Gammaretroviral Vector Product and Services
        7.5.4 Waisman Biomanufacturing Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Waisman Biomanufacturing Recent Developments/Updates
        7.5.6 Waisman Biomanufacturing Competitive Strengths & Weaknesses
    7.6 Creative-Biogene
        7.6.1 Creative-Biogene Details
        7.6.2 Creative-Biogene Major Business
        7.6.3 Creative-Biogene Gammaretroviral Vector Product and Services
        7.6.4 Creative-Biogene Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Creative-Biogene Recent Developments/Updates
        7.6.6 Creative-Biogene Competitive Strengths & Weaknesses
    7.7 Aldevron
        7.7.1 Aldevron Details
        7.7.2 Aldevron Major Business
        7.7.3 Aldevron Gammaretroviral Vector Product and Services
        7.7.4 Aldevron Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Aldevron Recent Developments/Updates
        7.7.6 Aldevron Competitive Strengths & Weaknesses
    7.8 Addgene
        7.8.1 Addgene Details
        7.8.2 Addgene Major Business
        7.8.3 Addgene Gammaretroviral Vector Product and Services
        7.8.4 Addgene Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Addgene Recent Developments/Updates
        7.8.6 Addgene Competitive Strengths & Weaknesses
    7.9 Oxford Biomedica
        7.9.1 Oxford Biomedica Details
        7.9.2 Oxford Biomedica Major Business
        7.9.3 Oxford Biomedica Gammaretroviral Vector Product and Services
        7.9.4 Oxford Biomedica Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Oxford Biomedica Recent Developments/Updates
        7.9.6 Oxford Biomedica Competitive Strengths & Weaknesses
    7.10 Thermo Fisher Scientific Inc.
        7.10.1 Thermo Fisher Scientific Inc. Details
        7.10.2 Thermo Fisher Scientific Inc. Major Business
        7.10.3 Thermo Fisher Scientific Inc. Gammaretroviral Vector Product and Services
        7.10.4 Thermo Fisher Scientific Inc. Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
        7.10.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    7.11 Fujifilm Corporation
        7.11.1 Fujifilm Corporation Details
        7.11.2 Fujifilm Corporation Major Business
        7.11.3 Fujifilm Corporation Gammaretroviral Vector Product and Services
        7.11.4 Fujifilm Corporation Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Fujifilm Corporation Recent Developments/Updates
        7.11.6 Fujifilm Corporation Competitive Strengths & Weaknesses
    7.12 Spark Therapeutics Inc
        7.12.1 Spark Therapeutics Inc Details
        7.12.2 Spark Therapeutics Inc Major Business
        7.12.3 Spark Therapeutics Inc Gammaretroviral Vector Product and Services
        7.12.4 Spark Therapeutics Inc Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Spark Therapeutics Inc Recent Developments/Updates
        7.12.6 Spark Therapeutics Inc Competitive Strengths & Weaknesses
    7.13 ABL Inc
        7.13.1 ABL Inc Details
        7.13.2 ABL Inc Major Business
        7.13.3 ABL Inc Gammaretroviral Vector Product and Services
        7.13.4 ABL Inc Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 ABL Inc Recent Developments/Updates
        7.13.6 ABL Inc Competitive Strengths & Weaknesses
    7.14 Boehringer Ingelheim International GmbH
        7.14.1 Boehringer Ingelheim International GmbH Details
        7.14.2 Boehringer Ingelheim International GmbH Major Business
        7.14.3 Boehringer Ingelheim International GmbH Gammaretroviral Vector Product and Services
        7.14.4 Boehringer Ingelheim International GmbH Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
        7.14.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
    7.15 Brammer Bio
        7.15.1 Brammer Bio Details
        7.15.2 Brammer Bio Major Business
        7.15.3 Brammer Bio Gammaretroviral Vector Product and Services
        7.15.4 Brammer Bio Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Brammer Bio Recent Developments/Updates
        7.15.6 Brammer Bio Competitive Strengths & Weaknesses
    7.16 Creative Biogene
        7.16.1 Creative Biogene Details
        7.16.2 Creative Biogene Major Business
        7.16.3 Creative Biogene Gammaretroviral Vector Product and Services
        7.16.4 Creative Biogene Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Creative Biogene Recent Developments/Updates
        7.16.6 Creative Biogene Competitive Strengths & Weaknesses
    7.17 General Electric
        7.17.1 General Electric Details
        7.17.2 General Electric Major Business
        7.17.3 General Electric Gammaretroviral Vector Product and Services
        7.17.4 General Electric Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 General Electric Recent Developments/Updates
        7.17.6 General Electric Competitive Strengths & Weaknesses
    7.18 Pfizer Inc
        7.18.1 Pfizer Inc Details
        7.18.2 Pfizer Inc Major Business
        7.18.3 Pfizer Inc Gammaretroviral Vector Product and Services
        7.18.4 Pfizer Inc Gammaretroviral Vector Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Pfizer Inc Recent Developments/Updates
        7.18.6 Pfizer Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gammaretroviral Vector Industry Chain
    8.2 Gammaretroviral Vector Upstream Analysis
        8.2.1 Gammaretroviral Vector Core Raw Materials
        8.2.2 Main Manufacturers of Gammaretroviral Vector Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Gammaretroviral Vector Production Mode
    8.6 Gammaretroviral Vector Procurement Model
    8.7 Gammaretroviral Vector Industry Sales Model and Sales Channels
        8.7.1 Gammaretroviral Vector Sales Model
        8.7.2 Gammaretroviral Vector Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gammaretroviral Vector Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Gammaretroviral Vector Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Gammaretroviral Vector Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Gammaretroviral Vector Production Value Market Share by Region (2018-2023)
    Table 5. World Gammaretroviral Vector Production Value Market Share by Region (2024-2029)
    Table 6. World Gammaretroviral Vector Production by Region (2018-2023) & (K Units)
    Table 7. World Gammaretroviral Vector Production by Region (2024-2029) & (K Units)
    Table 8. World Gammaretroviral Vector Production Market Share by Region (2018-2023)
    Table 9. World Gammaretroviral Vector Production Market Share by Region (2024-2029)
    Table 10. World Gammaretroviral Vector Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Gammaretroviral Vector Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Gammaretroviral Vector Major Market Trends
    Table 13. World Gammaretroviral Vector Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Gammaretroviral Vector Consumption by Region (2018-2023) & (K Units)
    Table 15. World Gammaretroviral Vector Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Gammaretroviral Vector Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Gammaretroviral Vector Producers in 2022
    Table 18. World Gammaretroviral Vector Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Gammaretroviral Vector Producers in 2022
    Table 20. World Gammaretroviral Vector Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Gammaretroviral Vector Company Evaluation Quadrant
    Table 22. World Gammaretroviral Vector Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Gammaretroviral Vector Production Site of Key Manufacturer
    Table 24. Gammaretroviral Vector Market: Company Product Type Footprint
    Table 25. Gammaretroviral Vector Market: Company Product Application Footprint
    Table 26. Gammaretroviral Vector Competitive Factors
    Table 27. Gammaretroviral Vector New Entrant and Capacity Expansion Plans
    Table 28. Gammaretroviral Vector Mergers & Acquisitions Activity
    Table 29. United States VS China Gammaretroviral Vector Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Gammaretroviral Vector Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Gammaretroviral Vector Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Gammaretroviral Vector Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Gammaretroviral Vector Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Gammaretroviral Vector Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Gammaretroviral Vector Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Gammaretroviral Vector Production Market Share (2018-2023)
    Table 37. China Based Gammaretroviral Vector Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Gammaretroviral Vector Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Gammaretroviral Vector Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Gammaretroviral Vector Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Gammaretroviral Vector Production Market Share (2018-2023)
    Table 42. Rest of World Based Gammaretroviral Vector Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Gammaretroviral Vector Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Gammaretroviral Vector Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Gammaretroviral Vector Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Gammaretroviral Vector Production Market Share (2018-2023)
    Table 47. World Gammaretroviral Vector Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Gammaretroviral Vector Production by Type (2018-2023) & (K Units)
    Table 49. World Gammaretroviral Vector Production by Type (2024-2029) & (K Units)
    Table 50. World Gammaretroviral Vector Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Gammaretroviral Vector Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Gammaretroviral Vector Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Gammaretroviral Vector Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Gammaretroviral Vector Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Gammaretroviral Vector Production by Application (2018-2023) & (K Units)
    Table 56. World Gammaretroviral Vector Production by Application (2024-2029) & (K Units)
    Table 57. World Gammaretroviral Vector Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Gammaretroviral Vector Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Gammaretroviral Vector Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Gammaretroviral Vector Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Novasep Basic Information, Manufacturing Base and Competitors
    Table 62. Novasep Major Business
    Table 63. Novasep Gammaretroviral Vector Product and Services
    Table 64. Novasep Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Novasep Recent Developments/Updates
    Table 66. Novasep Competitive Strengths & Weaknesses
    Table 67. MerckKGaA Basic Information, Manufacturing Base and Competitors
    Table 68. MerckKGaA Major Business
    Table 69. MerckKGaA Gammaretroviral Vector Product and Services
    Table 70. MerckKGaA Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. MerckKGaA Recent Developments/Updates
    Table 72. MerckKGaA Competitive Strengths & Weaknesses
    Table 73. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
    Table 74. Charles River Laboratories Major Business
    Table 75. Charles River Laboratories Gammaretroviral Vector Product and Services
    Table 76. Charles River Laboratories Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Charles River Laboratories Recent Developments/Updates
    Table 78. Charles River Laboratories Competitive Strengths & Weaknesses
    Table 79. UniQure N.V. Basic Information, Manufacturing Base and Competitors
    Table 80. UniQure N.V. Major Business
    Table 81. UniQure N.V. Gammaretroviral Vector Product and Services
    Table 82. UniQure N.V. Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. UniQure N.V. Recent Developments/Updates
    Table 84. UniQure N.V. Competitive Strengths & Weaknesses
    Table 85. Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
    Table 86. Waisman Biomanufacturing Major Business
    Table 87. Waisman Biomanufacturing Gammaretroviral Vector Product and Services
    Table 88. Waisman Biomanufacturing Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Waisman Biomanufacturing Recent Developments/Updates
    Table 90. Waisman Biomanufacturing Competitive Strengths & Weaknesses
    Table 91. Creative-Biogene Basic Information, Manufacturing Base and Competitors
    Table 92. Creative-Biogene Major Business
    Table 93. Creative-Biogene Gammaretroviral Vector Product and Services
    Table 94. Creative-Biogene Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Creative-Biogene Recent Developments/Updates
    Table 96. Creative-Biogene Competitive Strengths & Weaknesses
    Table 97. Aldevron Basic Information, Manufacturing Base and Competitors
    Table 98. Aldevron Major Business
    Table 99. Aldevron Gammaretroviral Vector Product and Services
    Table 100. Aldevron Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Aldevron Recent Developments/Updates
    Table 102. Aldevron Competitive Strengths & Weaknesses
    Table 103. Addgene Basic Information, Manufacturing Base and Competitors
    Table 104. Addgene Major Business
    Table 105. Addgene Gammaretroviral Vector Product and Services
    Table 106. Addgene Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Addgene Recent Developments/Updates
    Table 108. Addgene Competitive Strengths & Weaknesses
    Table 109. Oxford Biomedica Basic Information, Manufacturing Base and Competitors
    Table 110. Oxford Biomedica Major Business
    Table 111. Oxford Biomedica Gammaretroviral Vector Product and Services
    Table 112. Oxford Biomedica Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Oxford Biomedica Recent Developments/Updates
    Table 114. Oxford Biomedica Competitive Strengths & Weaknesses
    Table 115. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
    Table 116. Thermo Fisher Scientific Inc. Major Business
    Table 117. Thermo Fisher Scientific Inc. Gammaretroviral Vector Product and Services
    Table 118. Thermo Fisher Scientific Inc. Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Thermo Fisher Scientific Inc. Recent Developments/Updates
    Table 120. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    Table 121. Fujifilm Corporation Basic Information, Manufacturing Base and Competitors
    Table 122. Fujifilm Corporation Major Business
    Table 123. Fujifilm Corporation Gammaretroviral Vector Product and Services
    Table 124. Fujifilm Corporation Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Fujifilm Corporation Recent Developments/Updates
    Table 126. Fujifilm Corporation Competitive Strengths & Weaknesses
    Table 127. Spark Therapeutics Inc Basic Information, Manufacturing Base and Competitors
    Table 128. Spark Therapeutics Inc Major Business
    Table 129. Spark Therapeutics Inc Gammaretroviral Vector Product and Services
    Table 130. Spark Therapeutics Inc Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Spark Therapeutics Inc Recent Developments/Updates
    Table 132. Spark Therapeutics Inc Competitive Strengths & Weaknesses
    Table 133. ABL Inc Basic Information, Manufacturing Base and Competitors
    Table 134. ABL Inc Major Business
    Table 135. ABL Inc Gammaretroviral Vector Product and Services
    Table 136. ABL Inc Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. ABL Inc Recent Developments/Updates
    Table 138. ABL Inc Competitive Strengths & Weaknesses
    Table 139. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
    Table 140. Boehringer Ingelheim International GmbH Major Business
    Table 141. Boehringer Ingelheim International GmbH Gammaretroviral Vector Product and Services
    Table 142. Boehringer Ingelheim International GmbH Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Boehringer Ingelheim International GmbH Recent Developments/Updates
    Table 144. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
    Table 145. Brammer Bio Basic Information, Manufacturing Base and Competitors
    Table 146. Brammer Bio Major Business
    Table 147. Brammer Bio Gammaretroviral Vector Product and Services
    Table 148. Brammer Bio Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Brammer Bio Recent Developments/Updates
    Table 150. Brammer Bio Competitive Strengths & Weaknesses
    Table 151. Creative Biogene Basic Information, Manufacturing Base and Competitors
    Table 152. Creative Biogene Major Business
    Table 153. Creative Biogene Gammaretroviral Vector Product and Services
    Table 154. Creative Biogene Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Creative Biogene Recent Developments/Updates
    Table 156. Creative Biogene Competitive Strengths & Weaknesses
    Table 157. General Electric Basic Information, Manufacturing Base and Competitors
    Table 158. General Electric Major Business
    Table 159. General Electric Gammaretroviral Vector Product and Services
    Table 160. General Electric Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. General Electric Recent Developments/Updates
    Table 162. Pfizer Inc Basic Information, Manufacturing Base and Competitors
    Table 163. Pfizer Inc Major Business
    Table 164. Pfizer Inc Gammaretroviral Vector Product and Services
    Table 165. Pfizer Inc Gammaretroviral Vector Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 166. Global Key Players of Gammaretroviral Vector Upstream (Raw Materials)
    Table 167. Gammaretroviral Vector Typical Customers
    Table 168. Gammaretroviral Vector Typical Distributors
List of Figure
    Figure 1. Gammaretroviral Vector Picture
    Figure 2. World Gammaretroviral Vector Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gammaretroviral Vector Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Gammaretroviral Vector Production (2018-2029) & (K Units)
    Figure 5. World Gammaretroviral Vector Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Gammaretroviral Vector Production Value Market Share by Region (2018-2029)
    Figure 7. World Gammaretroviral Vector Production Market Share by Region (2018-2029)
    Figure 8. North America Gammaretroviral Vector Production (2018-2029) & (K Units)
    Figure 9. Europe Gammaretroviral Vector Production (2018-2029) & (K Units)
    Figure 10. China Gammaretroviral Vector Production (2018-2029) & (K Units)
    Figure 11. Japan Gammaretroviral Vector Production (2018-2029) & (K Units)
    Figure 12. Gammaretroviral Vector Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 15. World Gammaretroviral Vector Consumption Market Share by Region (2018-2029)
    Figure 16. United States Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 17. China Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 18. Europe Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 19. Japan Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 22. India Gammaretroviral Vector Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Gammaretroviral Vector by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Gammaretroviral Vector Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Gammaretroviral Vector Markets in 2022
    Figure 26. United States VS China: Gammaretroviral Vector Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Gammaretroviral Vector Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gammaretroviral Vector Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Gammaretroviral Vector Production Market Share 2022
    Figure 30. China Based Manufacturers Gammaretroviral Vector Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Gammaretroviral Vector Production Market Share 2022
    Figure 32. World Gammaretroviral Vector Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Gammaretroviral Vector Production Value Market Share by Type in 2022
    Figure 34. Lentiviral Vectors
    Figure 35. Adenoviral Vectors
    Figure 36. Adeno-Associated Viral Vectors
    Figure 37. Other
    Figure 38. World Gammaretroviral Vector Production Market Share by Type (2018-2029)
    Figure 39. World Gammaretroviral Vector Production Value Market Share by Type (2018-2029)
    Figure 40. World Gammaretroviral Vector Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Gammaretroviral Vector Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Gammaretroviral Vector Production Value Market Share by Application in 2022
    Figure 43. Gene Therapy
    Figure 44. Vaccinology
    Figure 45. Other
    Figure 46. World Gammaretroviral Vector Production Market Share by Application (2018-2029)
    Figure 47. World Gammaretroviral Vector Production Value Market Share by Application (2018-2029)
    Figure 48. World Gammaretroviral Vector Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Gammaretroviral Vector Industry Chain
    Figure 50. Gammaretroviral Vector Procurement Model
    Figure 51. Gammaretroviral Vector Sales Model
    Figure 52. Gammaretroviral Vector Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source